# Peptides for focus and mood

Source: https://aminodesk.com/goals/focus-and-mood
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Semax and Selank are approved medicines in Russia, with small trials behind them. No compound sold for focus or mood has a large controlled trial in a Western population.

**The short version**

- **Semax:** the nasal form can be compounded on prescription under the October 2026 policy. Its strongest evidence is in stroke care, not everyday focus.
- **Selank:** Russian trials for anxiety, no Western trials and no US route.
- **Methylene blue:** carries a boxed warning for serotonin syndrome when combined with SSRIs, SNRIs, MAOIs and opioids.
- **Dihexa and Pinealon:** no controlled human trials.
- **If anxiety or low mood is persistent,** a clinician is the better first stop.

## Better studied

Grades describe the evidence for a compound's best-studied use, which is not always the use on this page. The summary under each name says what was actually tested. [How the grades work](https://aminodesk.com/finder).

### [Methylene blue](https://aminodesk.com/library/methylene-blue)

Grade A FDA-approved

An approved prescription drug for one rare blood condition, now sold in dropper bottles for focus. Carries a boxed warning for serotonin syndrome with SSRIs and similar drugs.

## Little or no human evidence

### [Semax](https://aminodesk.com/library/semax)

Grade C 2026 policy

A nasal peptide from Russian research, now legally compoundable as a nasal spray. Marketed for focus and recovery after stroke.

### [Selank](https://aminodesk.com/library/selank)

Grade C No legal route

Approved in Russia as an anti-anxiety nasal spray, with small trials suggesting benzodiazepine-like effect without sedation. No Western trials and no US route.

### [Dihexa](https://aminodesk.com/library/dihexa)

Grade D No legal route

Sold for memory. No human data of any kind, and the paper describing how it was supposed to work has been retracted.

### [Pinealon](https://aminodesk.com/library/pinealon)

Grade D No legal route

A Russian three-amino-acid 'bioregulator' sold for memory and brain aging. Evidence is cell and rodent work from one research group.

## What you can legally get

- **FDA-approved, by prescription:** [Methylene blue](https://aminodesk.com/library/methylene-blue)
- **Compoundable on prescription under the October 2026 policy:** [Semax](https://aminodesk.com/library/semax)
- **No legal route in the US:** [Selank](https://aminodesk.com/library/selank), [Dihexa](https://aminodesk.com/library/dihexa), [Pinealon](https://aminodesk.com/library/pinealon)

Products sold online as "research use only" are outside every one of these routes. See [how to vet a provider](https://aminodesk.com/providers).

## Keep reading

- [Semax in detail](https://aminodesk.com/library/semax)
- [Methylene blue and the interaction warning](https://aminodesk.com/library/methylene-blue)
- [Filter all 40 compounds by goal and legal status](https://aminodesk.com/finder)

This page summarizes our compound pages. The sources for every claim are listed on each of those pages.

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
